Cargando…
Central versus Peripheral CTEPH—Clinical and Hemodynamic Specifications
Background and Objectives: Chronic thromboembolic pulmonary hypertension (CTEPH) is a chronic progressive disease, resulting from persistent arterial obstruction combined with small-vessel remodeling. Central and peripheral CTEPH are distinguished, according to the dominant lesion’s location. This i...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696046/ https://www.ncbi.nlm.nih.gov/pubmed/36363494 http://dx.doi.org/10.3390/medicina58111538 |
_version_ | 1784838218929143808 |
---|---|
author | Kaldararova, Monika Simkova, Iveta Bohacekova, Marcela Reptova, Adriana Hlavata, Tereza Pacak, Jozef Lindner, Jaroslav Jansa, Pavel |
author_facet | Kaldararova, Monika Simkova, Iveta Bohacekova, Marcela Reptova, Adriana Hlavata, Tereza Pacak, Jozef Lindner, Jaroslav Jansa, Pavel |
author_sort | Kaldararova, Monika |
collection | PubMed |
description | Background and Objectives: Chronic thromboembolic pulmonary hypertension (CTEPH) is a chronic progressive disease, resulting from persistent arterial obstruction combined with small-vessel remodeling. Central and peripheral CTEPH are distinguished, according to the dominant lesion’s location. This is important for surgical or percutaneous interventional assessment or for medical treatment. Material and Methods: Eighty-one patients (51 male/30 female) with confirmed CTEPH were analyzed, while the CENTRAL type included 51 patients (63%) and the PERIPHERAL type 30 patients (37%). Results: A significant difference in CENTRAL type vs. PERIPHERAL type was determined in gender (male 72.5% vs. 46.7%; p = 0.0198). No difference was found in age, functional status, or echocardiographic parameters. Invasive hemodynamic parameters showed a significant difference in mean pulmonary arterial pressure (46 vs. 58 mmHg; p = 0.0002), transpulmonary gradient (34 vs. 47 mmHg; p = 0.0005), and cardiac index (2.04 vs. 2.5 L.min.m(2); p = 0.02) but not in pulmonary vascular resistance. Risk factors showed a significant difference only in acute pulmonary embolism (93.8% vs. 60%; p = 0.0002) and malignancy (2% vs. 13.3%; p = 0.0426). Conclusions: Our study showed hemodynamic differences between CENTRAL type vs. PERIPHERAL type CTEPH with a worse hemodynamic picture in CENTRAL form. This may indicate a different pathophysiological response and/or possible additional influences contributing especially to the peripheral pulmonary bed affection. |
format | Online Article Text |
id | pubmed-9696046 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96960462022-11-26 Central versus Peripheral CTEPH—Clinical and Hemodynamic Specifications Kaldararova, Monika Simkova, Iveta Bohacekova, Marcela Reptova, Adriana Hlavata, Tereza Pacak, Jozef Lindner, Jaroslav Jansa, Pavel Medicina (Kaunas) Article Background and Objectives: Chronic thromboembolic pulmonary hypertension (CTEPH) is a chronic progressive disease, resulting from persistent arterial obstruction combined with small-vessel remodeling. Central and peripheral CTEPH are distinguished, according to the dominant lesion’s location. This is important for surgical or percutaneous interventional assessment or for medical treatment. Material and Methods: Eighty-one patients (51 male/30 female) with confirmed CTEPH were analyzed, while the CENTRAL type included 51 patients (63%) and the PERIPHERAL type 30 patients (37%). Results: A significant difference in CENTRAL type vs. PERIPHERAL type was determined in gender (male 72.5% vs. 46.7%; p = 0.0198). No difference was found in age, functional status, or echocardiographic parameters. Invasive hemodynamic parameters showed a significant difference in mean pulmonary arterial pressure (46 vs. 58 mmHg; p = 0.0002), transpulmonary gradient (34 vs. 47 mmHg; p = 0.0005), and cardiac index (2.04 vs. 2.5 L.min.m(2); p = 0.02) but not in pulmonary vascular resistance. Risk factors showed a significant difference only in acute pulmonary embolism (93.8% vs. 60%; p = 0.0002) and malignancy (2% vs. 13.3%; p = 0.0426). Conclusions: Our study showed hemodynamic differences between CENTRAL type vs. PERIPHERAL type CTEPH with a worse hemodynamic picture in CENTRAL form. This may indicate a different pathophysiological response and/or possible additional influences contributing especially to the peripheral pulmonary bed affection. MDPI 2022-10-27 /pmc/articles/PMC9696046/ /pubmed/36363494 http://dx.doi.org/10.3390/medicina58111538 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kaldararova, Monika Simkova, Iveta Bohacekova, Marcela Reptova, Adriana Hlavata, Tereza Pacak, Jozef Lindner, Jaroslav Jansa, Pavel Central versus Peripheral CTEPH—Clinical and Hemodynamic Specifications |
title | Central versus Peripheral CTEPH—Clinical and Hemodynamic Specifications |
title_full | Central versus Peripheral CTEPH—Clinical and Hemodynamic Specifications |
title_fullStr | Central versus Peripheral CTEPH—Clinical and Hemodynamic Specifications |
title_full_unstemmed | Central versus Peripheral CTEPH—Clinical and Hemodynamic Specifications |
title_short | Central versus Peripheral CTEPH—Clinical and Hemodynamic Specifications |
title_sort | central versus peripheral cteph—clinical and hemodynamic specifications |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696046/ https://www.ncbi.nlm.nih.gov/pubmed/36363494 http://dx.doi.org/10.3390/medicina58111538 |
work_keys_str_mv | AT kaldararovamonika centralversusperipheralctephclinicalandhemodynamicspecifications AT simkovaiveta centralversusperipheralctephclinicalandhemodynamicspecifications AT bohacekovamarcela centralversusperipheralctephclinicalandhemodynamicspecifications AT reptovaadriana centralversusperipheralctephclinicalandhemodynamicspecifications AT hlavatatereza centralversusperipheralctephclinicalandhemodynamicspecifications AT pacakjozef centralversusperipheralctephclinicalandhemodynamicspecifications AT lindnerjaroslav centralversusperipheralctephclinicalandhemodynamicspecifications AT jansapavel centralversusperipheralctephclinicalandhemodynamicspecifications |